<html><head><script id="decision-support-view" type="application/json">{
  "dsViewId": "TIMI_STEMI.v1",
  "language": {
    "originalLanguage": {
      "terminologyId": {
        "name": "ISO_639-1",
        "value": "ISO_639-1"
      },
      "codeString": "en"
    }
  },
  "decisionSupportViewDefinitions": {
    "sv": {
      "name": "TIMI-Score för ST-höjningsinfarkt",
      "description": "30-dagarsmortalitet hos patienter med trombolysbehandlad ST-höjningsinfarkt"
    },
    "en": {
      "name": "TIMI for STEMI",
      "description": "30 day mortality risk among patients with STEMI"
    }
  },
  "resourceDescription": {
    "originalAuthor": {
      "date": "2017-01-03",
      "name": "Syeeda S Farruque",
      "organisation": "Cambio Healthcare Systems"
    },
    "otherContributors": [
      "Dennis Forslund"
    ],
    "details": {
      "sv": {
        "purpose": "Att utvärdera 30-dagarsmortalitet hos patienter med trombolysbehandlad ST-höjningsinfarkt. ",
        "keywords": [
          "TIMI risk for STEMI",
          "TIMI",
          "trombolys",
          "30-dagarsmortalitet",
          "ST-höjning",
          "ST-höjningsinfarkt",
          "LBBB",
          "STEMI"
        ],
        "use": "Instrumentet inkluderar utöver patienter med trombolysbehandlad ST-höjningsinfarkt även patienter med LBBB (vänstersidigt skänkelblock), vilket i detta sammanhang jämställs med STEMI.\n\nÅlderskategori poängsätts enligt; \u003c65 \u003d 0p, 65-74 \u003d 2p, \u003e75 \u003d 3p. \n\nFörekomst av diabetes mellitus, hypertoni eller angina pectoris ger 1p. Övriga faktorer som vid förekomst bidrar med en poäng är ST-höjningsinfarkt eller LBBB, behandling inom 4h och vikt under 67kg.\n\nEn hjärtfrekvens mätt över 100 slag/min eller en Killip-klass mellan II-IV genererar 2p till totala summan. \n\nSystoliskt blodtryck \u003c100mmHg ger 3p.\n\nTotal poäng uppgår till maximalt 14p. Poäng om \u003e8p tolkas som förhöjd risk.",
        "misuse": "Ej avsedd för patienter med kardiogen chock eller svår hypertension (\u003e180/\u003e110) eller patienter som genomgår PCI-behandling.",
        "copyright": "Cambio Healthcare Systems"
      },
      "en": {
        "purpose": "Its purpose is to asscertain the 30 day mortality risk among patients with ST elevation Myocardial Infarction (STEMI) on fibrinolytics.",
        "keywords": [
          "TIMI risk for STEMI",
          "myocardial infarction",
          "fibrinolytics",
          "30 day mortality",
          "ST elevation"
        ],
        "use": "This score also included patients with left bundle branch block, which was thought to be a STEMI equivalent.\n\nAge was divided into 2 groups, with 2 points for ages ranging from 65 to 74 years and 3 points for ages\nthat were \u003e75 years.  All those below 65yrs were scored \u003d 0\n\n3 Historical variables were scored overall as \u003d 1 if any of them were present (diabetes, history of angina, and history of hypertension). \nThe other variables that scored 1 were a presence of anterior ST elevation or LBBB (Left bundle branch block), a time to treatment that was greater than 4hrs and a weight below 67Kg\n\nIf the patient\u0027s heart rate was \u003e 100bpm or their Killip classification was between II and IV, they scored 2 for each of those variables\n\nA systolic BP of \u003c 100mmHg was scored 3 points.\n\nScore ranges from 0 to a total score of 14 but anything above 8 would be considered of high risk.",
        "misuse": "The tool should not include patients with cardiogenic shock, patients undergoing percutaneous coronary intervention (PCI) as this tool is inferior to that, nor those suffering from severe hypertension (\u003e 180/\u003e110)",
        "copyright": "Cambio Healthcare Systems"
      }
    },
    "otherDetails": {
      "references": "David A. Morrow, et. al. TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation: An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy Circulation.2000; 102: 2031-2037 doi: 10.1161/01.CIR.102.17.2031"
    }
  },
  "alertGuideIds": [],
  "executionGuideIds": [
    "TIMI_STEMI"
  ],
  "alertBindings": {},
  "termDefinitions": {
    "sv": {
      "id": "sv",
      "terms": {
        "vt0001": {
          "id": "vt0001",
          "text": "Referenser"
        }
      }
    },
    "en": {
      "id": "en",
      "terms": {
        "vt0001": {
          "id": "vt0001",
          "text": "References"
        }
      }
    }
  }
}</script></head><body></body></html>